Similarly, the inhibition of NF-κB in pancreatic cancer suppresses the expression of EMT markers (SNAI1, SNAI2, and VIM) and reduces invasive capacity, which is reversed by IKK activation [269]. Here, NFKB1 is linked to pancreatic neoplasm.